18F-Fluciclovine PET Detected Early Tumor Recurrence in Prostatectomy Bed With Low PSA of 0.3 ng/mL But Negative on 18F-PSMA PET Scan

被引：3

作者：

Nguyen, Trinh T. ^{[1
]}

Bhosale, Priya R. ^{[2
]}

Lu, Yang ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Div Diagnost Imaging, 1400 Pressler St, Unit1483, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Abdominal Imaging, Div Diagnost Imaging, Houston, TX USA

来源：

CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 01期

关键词：

PSMA; PET/CT; fluciclovine; MRI; prostate cancer; metastasis; CANCER PATIENTS; RISING PSA;

D O I：

10.1097/RLU.0000000000004356

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

A 58-year-old man with metastatic prostate cancer was treated with prostatectomy, radiation therapy to bone metastasis, and androgen deprivation therapy plus abiraterone. He had posttreatment nadir PSA of 0.1 ng/mL. A follow-up F-18-fluciclovine PET performed with PSA of 0.3 ng/mL showed a focal tracer-avid lesion in the left prostatectomy bed. This lesion was negative on F-18-DCFPyL PET/CT, but with typical MRI features for disease recurrence. Minimal urinary activity of fluciclovine helped detection of local disease recurrence in the prostatectomy bed.

引用

页码：69 / 70

页数：2

共 50 条

[1] 68Ga-PSMA-11 PET Identified Tumor Recurrence in Prostatectomy Bed With Rising PSA of 0.9 ng/mL but Negative on MRI and 18F-Fluciclovine PET Scan
Xu, Guofan
Lu, Yang
CLINICAL NUCLEAR MEDICINE, 2022, 47 (04) : 378 - 379
[2] The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
Wang, Rang
Shen, Guohua
Huang, Mingxing
Tian, Rong
FRONTIERS IN ONCOLOGY, 2021, 11
[3] Therapeutic implications of 18F-PSMA PET/MRI in patients with prostate cancer and biochemical recurrence (PSA < 2 ng/ml) after prostatectomy
Garcia, J.
Compte, A.
Kauak, M.
Bassa, P.
Blanch, T.
Pastor, J.
Riera, E.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S526 - S527
[4] Gastrointestinal Stromal Tumor Incidentally Detected on 18F-Fluciclovine PET/CT
Raghavan, Kesav
Flavell, Robert R.
Westphalen, Antonio C.
Behr, Spencer C.
CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : 345 - 347
[5] Solitary Penile Metastasis of Prostate Cancer on 18F-Fluciclovine PET/CT Imaging in a Patient With PSA of 1 ng/mL
Salavati, Ali
Schik, Allyssa N.
Koksel, Yasemin
Gencturk, Mehmet
Froelich, Jerry W.
CLINICAL NUCLEAR MEDICINE, 2020, 45 (05) : 389 - 391
[6] Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT
Pernthaler, Birgit
Nazerani Hooshmand, Tina
Igrec, Jasminka
Kvaternik, Herbert
Aigner, Reingard M.
CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : E231 - E232
[7] 18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence
Marafi, Fahad
Sasikumar, Arun
Fathallah, Wael
Esmail, Abdulredh
CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : E61 - E62
[8] Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels
Marcus, Charles
Abiodun-Ojo, Olayinka A.
Jani, Ashesh B.
Schuster, David M.
AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 11 (05): : 406 - 414
[9] [18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine
Loeff, Cato C.
van Gemert, Willemijn
Prive, Bastiaan M.
van Oort, Inge M.
Hermsen, Rick
Somford, Diederik M.
Nagarajah, James
Heijmen, Linda
Janssen, Marcel J. R.
EJNMMI REPORTS, 2024, 8 (01)
[10] Pictorial essay: incidental findings on 18F-Fluciclovine PET/CT scan
Cinzia Romagnolo
Chiara Cottignoli
Andrea Palucci
Giuseppina Biscontini
Fabio Massimo Fringuelli
Luca Burroni
Clinical and Translational Imaging, 2021, 9 : 189 - 198

← 1 2 3 4 5 →